Screening for gene deletions and known mutations in 13 patients with ornithine transcarbamylase deficiency

Peg J. Suess, Michael Y. Tsai, Robert A. Holzknecht, Mia Horowitz, Mendel Tuchman

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

We analyzed DNA from 13 males with ornithine transcarbamylase (OTC) deficiency for gene deletions and known point mutations using the polymerase chain reaction (PCR), allelle-specific oligonucleotide (ASO) hybridization, and Southern blotting with full-length OTC cDNA and exon-specific probes. Three patients were found to have deletions: one was missing the whole OTC gene; a second patient had a deletion of both exon 7 and 8; and the third had a deletion of exon 9. Only one of the remaining 10 patients had a known point mutation consisting of a G-to-A change in nucleotide 422 of the sense strand resulting in a glutamine substitution for arginine at amino acid 109 of the mature OTC protein. This study describes the integration of various molecular methods to screen OTC-deficient patients for deletions and points mutations. Two new deletions within the OTC gene are described.

Original languageEnglish (US)
Pages (from-to)250-259
Number of pages10
JournalBiochemical Medicine and Metabolic Biology
Volume47
Issue number3
DOIs
StatePublished - Jun 1992

Bibliographical note

Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Screening for gene deletions and known mutations in 13 patients with ornithine transcarbamylase deficiency'. Together they form a unique fingerprint.

Cite this